A comparative single-dose bioequivalence study of two Glibenclamide brands among healthy volunteers. (c2000)
Glibenclamide is a second generation sulfonylurea oral hypoglycemic agent that plays an important role in the therapy of type II diabetes mellitus (DM-II); moreover. glibenclamide (Glibamid®) is being extensively used among diabetics in the middle east, including Lebanon where this drug is manufactu...
Saved in:
| Main Author: | |
|---|---|
| Format: | masterThesis |
| Published: |
2000
|
| Subjects: | |
| Online Access: | http://hdl.handle.net/10725/776 https://doi.org/10.26756/th.2000.6 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|